| No. | Drug Name | Active Ingredient | Date | What It’s Used For |
| 23. | Orbactiv | oritavancin | 8/6/2014 | To treat adults with skin infections
* D( u, z) u$ W' L6 z/ V! j. m0 E+ N Press Release |
| 22. | | empagliflozin | 8/1/2104 | To improve gylcemic control in adults with type 2 diabetes
5 L$ W" t# b3 P( q9 { Press Release |
| 21. | | olodaterol | 7/31/2014 | To treat chronic obstructive pulmonary disease
& b& ?. k3 g- U4 F2 q4 Z: T1 d$ q Press Release |
| 20. 0 r i2 l- g7 |- N. x
) A" n: t2 C& e$ s6 a1 Y
| | idelalisib | 7/23/2014 | To treat patients with trhee types of blood cancers R/ h- B, W* E7 a* L0 j2 z
Press Release |
| 19. | Kerydin
6 z/ ~! z8 T2 X 5 A" Q! X4 x% J6 r' c, ~9 a, n
| tavaborole | 7/7/2014 | For the topical treatment of onychomycosis of the toenails
+ l' m9 T3 n! |- \- y6 D/ E (No Press Release) |
| 18. | | belinostat | 7/3/2014 | To treat patients with peripheral T-cell lymphoma (PTCL) : S* V( C9 }0 a3 K2 b6 R
Press Release |
| 17. | | tedizolid phosphate | 6/20/2014 | To treat adults with skin infections- V3 C# n) J' @
Press Release |
| 16. | Jublia
8 t5 Z& x" J* e: b' B/ I1 c # Y4 S+ u* Z8 }
| efinaconazole | 6/6/2014 | Treat mild to moderate onychomycosis (fungal infection); M( K, B/ Q$ f8 m
No Press Release |
| 15. | Dalvance) C8 t" N" T: G: X8 ^2 z( l2 q
7 W- S( _* } _3 s
| dalbavancin | 5/23/2014 | To treat adults with skin infections7 j+ W) o( Z- Q( a" i9 r( y+ }
Press Release |
| 14. | Entyvio
( P0 l6 u5 T4 R8 i) s2 M 0 u% Q# W. s0 D8 C0 W
| vedolizumab | 5/20/2014 | To treat adult patients with moderate to severe ulcerative colitis and adult patients with moderate to severe Crohn‘s disease U: y: M: a1 H
Press Release |
| 13. | Zontivity
+ Q& Z6 |, ]; Q- D# S3 a + \/ F% m# n5 O8 ?$ F
| vorapaxar | 5/8/2014 | To reduce the risk of heart attacks and stroke in high-risk patients7 f* `# F/ `& k2 }
Press Release |
| 12. | | ceritinib | 4/29/2014 | To treat patients with a certain type of late-stage (metastatic) non-small cell lung cancer (NSCLC)0 h. d: K8 `5 ]; C/ Q# [7 z
Press Release |
| 11. | | siltuximab | 4/23/2014 | To treat patients with multicentric Castleman’s disease (MCD), a rare disorder similar to lymphoma (cancer of the lymph nodes)
0 m# ?! M9 x8 {- R9 ? Press Release |
| 10. | | ramucirumab | 4/21/2014 | To treat patients with advanced stomach cancer or gastroesophageal junction adenocarcinoma# I& y R3 L( I- l4 e, U
Press Release |
| 9. | | albiglutide | 4/15/2014 | To improve glycemic control, along with diet and exercise, in adults with type 2 diabetes
9 e8 L8 e5 ?0 m8 t/ o0 G Press Release |
| 8. | | apremilast | 3/21/2014 | To treat adults with active psoriatic arthritis (PsA)
+ M, ~* u! p& {1 }: X2 B+ E Press Release |
| 7. | | miltefosine | 3/19/2014 | To treat a tropical disease called leishmaniasis. U: h. L7 N5 P& @. Q8 o9 c) O: _
Press Release |
| 6. | | florbetaben F 18 injection | 3/19/2014 | For Positron EmissionTomography (PET) imaging of the brain |
| 5. | | metreleptin for injection | 2/24/2014 | To treat the complications of leptin deficiency: K3 Z! B7 c8 R8 V- a. |
Press Release |
| 4. | | droxidopa | 2/18/2014 | To treat neurogenic orthostatic hypotension (NOH)( K# V7 T7 Q, Z
Press Release |
| 3. | | elosulfase alfa | 2/14/2014 | Treatment for Mucopolysaccharidosis Type IVA (Morquio A syndrome)3 H9 [- s8 v' S
Press Release |
| 2. | | tasimelteon | 1/31/2014 | To treat non-24- hour sleep-wake disorder (“non-24”) in totally blind individuals. Non-24 is a chronic circadian rhythm (body clock) disorder in the blind that causes problems with the timing of sleep.Press Release |
| 1. | | dapaglifozin | 1/8/2014 | To improve glycemic control, along with diet and exercise, in adults with type 2 diabetes2 x7 }5 a* t1 b/ }2 A) o; K* J
Press Release |
|手机版|药群论坛
( 蜀ICP备15007902号 )
收藏
支持
反对